摘要
【目的】探讨炎症性慢性骨盆疼痛综合征(ⅢA型CPPS)患者前列腺液白细胞计数与临床症状以及治疗后症状改善程度的关系。【方法】选择2004年9月至12月我院泌尿外科门诊91名ⅢA型CPPS患者,首诊时采用慢性前列腺炎症状评分(CPSI)问卷调查,同时行前列腺液白细胞计数,予以口服氟喹诺酮治疗4周后随访,再次行CPSI问卷调查。【结果】治疗后CPSI各项评分均有下降(P<0.01)。按前列腺液白细胞计数分组,首诊时CPSI的组间差异无统计学意义(P>0.05),治疗后CPSI下降幅度的组间差异也无统计学意义(P>0.05)。首诊时CPSI以及治疗后CPSI下降幅度与前列腺液白细胞计数均无相关性(P>0.05)。【结论】ⅢA型CPPS患者前列腺液白细胞计数与临床症状的严重程度不相关,与治疗后的症状改善程度也不相关。提示前列腺液白细胞计数对评估ⅢA型CPPS患者的病情以及指导治疗的意义不大。
[Objective]To investigate associations between leukoeytes in prostatic fluid with symptoms in men with inflammatory chronic pelvic pain syndrome （ Ⅲ A, CPPS） as well as their responses to therapy. [Methods]Between September and December in 2004, 167 patients were diagnosed as Ⅲ A, CPPS at a visit to our urology clinic. Chronic Prostatitis Symptom Index（CPSI） was used to measure symptoms. Leukocytes in prostatic fluid were counted at the same time. All patients were treated with fluoroquinolones for 4 weeks, and their symptoms were measured again with CPSI after 4 weeks. [Resuhs]After antibiotic therapy, all CPSI scores decreased significantly （ P 〈0. 01）. There was no significant difference in all initial CPSI scores to stratification based on leukocyte count （ P 〉0.05）. There was no significant difference in all the changes in CPSI after therapy to the above-mentioned stratification, too（ P 〉0.05）. Leukocytes in prostatic fluid correlated with neither initial CPSI nor the changes in CPSI after antibiotic therapy（ P 〉0.05）. [Conclusion]Leukocytes in prostatic fluid correlate with neither severity of symptoms nor response to therapy. Prostatic fluid leukocyte count is not good tools for assessment and management of men with Ⅲ A, CPPS.
出处
《医学临床研究》
CAS
2006年第1期20-22,共3页
Journal of Clinical Research
关键词
前列腺炎
慢性病
白细胞计数
prostatitis
chronic disease
leukocyte count
